Sorrento Therapeutics Inc (SRNE): What are the potential earnings in Sorre...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Wednesday, 07/22/2020 12:41:13 PM

Wednesday, July 22, 2020 12:41:13 PM

What are the potential earnings in Sorrento's three program areas two years from now?

PAIN. RTX in knee, arthritic and cancer pain and SP-102 sciatic pain.
Potential earnings $3 billion

CANCER. Abivirtinib in cancer indications, CAR-T, DAR-T, DAR-NK and Sofusa.
Potential earnings $3 billion

COVID-19. COVI-TRACK, COVI-GUARD, COVI-SHIELD, COVIDTRAP, VIVA-19,Abivir...
Potential earnings. $3 billion.

Total potential earnings $9 billion.
Shares outstanding. 300 million (currently 209 million)
Earnings per share = $30
P/E ratio = 10
Share price = $300

Or will Sorrento be bought out by then?

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM